EUVIMEDEUVIMED entdecken
Crossref

An efficient step-by-step approach to select pleiotropic drug candidates against Alzheimer's disease: The discovery of neocopride

Christophe Rochais, Cédric Lecoutey, Georgia Culley, Thomas Curel, Audrey Davis, Emilie Duval, Laura Rouvière, Alexandre Henriques, Romain Legrand, Sylvie Claeysen iD, Noëlle Callizot, Patrick Dallemagne iD

Journal of Alzheimer’s Disease · 2026-04 · 110 (4) · 1654-1666

DOI: 10.1177/13872877261424925 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Alzheimer’s Disease, online erschienen am 13.03.2026. Verfasst von Christophe Rochais und 11 weiteren Autor:innen. Beteiligte Einrichtung: Université Caen Normandie, Normandie Univ, CERMN UR4258, Caen, France. Hauptthemen laut MEDLINE: Alzheimer Disease, Neuroprotective Agents, Drug Discovery. Die Arbeit nennt 28 Literaturangaben. Gefördert von: Normandie Valorisation, Normandie Region-France- and the European Community.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The selection of novel chemical entities that have a reasonable chance of showing clinical efficacy in AD patients is challenging.

Objective

The aim of this article is to outline the steps involved in a selection process that can result in the identification of potential preclinical candidates.

Methods

We used a cellular model of injured hippocampal neurons, for the validation of the association of the targets considered (acetylcholinesterase and 5-HT 4 receptor) and for the selection of multi-target ligands active in cellulo . The mechanism of the plural action of the best compound, we called neocopride, was deciphered using several in cellulo approaches. Finally, the protective effect of neocopride against short-term memory impairment was investigated in mice intoxicated with amyloid- β peptide.

Results

Our results show that neocopride displays strong protective effects against short-term memory disorders after oral administration at a dose of 3 mg/kg.

Conclusions

The findings suggest that neocopride is a promising drug candidate It is currently undergoing preclinical regulatory trials for AD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseNeuroprotective AgentsDrug DiscoveryAnimalsMiceAmyloid beta-PeptidesHumansMaleHippocampusDisease Models, AnimalAcetylcholinesteraseNeuronsPeptide FragmentsReceptors, Serotonin, 5-HT4

Stichwörter der Autor:innen

5-HT4 receptorAlzheimer's diseaseacetylcholinesterasedrug designmulti-target directed ligands

Substanzen

Amyloid beta-PeptidesNeuroprotective AgentsAcetylcholinesterasePeptide FragmentsReceptors, Serotonin, 5-HT4

Autor:innen und Institutionen

  • Université Caen Normandie, Normandie Univ, CERMN UR4258, Caen, France.
  • Neuro-Sys, Gardanne, France.
  • IGF, Univ. Montpellier, CNRS, INSERM, Montpellier, France.
  • RONOMA Pharma, Saint Etienne du Rouvray, France.

ORCID-Profile: Sylvie Claeysen, Patrick Dallemagne

Förderung

  • Normandie Valorisation
  • Normandie Region-France- and the European Community

Zitieren

APA

Rochais, C., Lecoutey, C., Culley, G., Curel, T., Davis, A., Duval, E., Rouvière, L., Henriques, A., Legrand, R., Claeysen, S., Callizot, N., & Dallemagne, P. (2026). An efficient step-by-step approach to select pleiotropic drug candidates against Alzheimer's disease: The discovery of neocopride. Journal of Alzheimer’s Disease, 110(4), 1654-1666. https://doi.org/10.1177/13872877261424925

Vancouver

Rochais C, Lecoutey C, Culley G, Curel T, Davis A, Duval E, et al. An efficient step-by-step approach to select pleiotropic drug candidates against Alzheimer's disease: The discovery of neocopride. Journal of Alzheimer’s Disease. 2026;110(4):1654-1666. doi:10.1177/13872877261424925

BibTeX
@article{Rochais2026,
  author = {Rochais, Christophe and Lecoutey, Cédric and Culley, Georgia and Curel, Thomas and Davis, Audrey and Duval, Emilie and Rouvière, Laura and Henriques, Alexandre and Legrand, Romain and Claeysen, Sylvie and Callizot, Noëlle and Dallemagne, Patrick},
  title = {An efficient step-by-step approach to select pleiotropic drug candidates against Alzheimer's disease: The discovery of neocopride},
  journal = {Journal of Alzheimer’s Disease},
  year = {2026},
  volume = {110},
  number = {4},
  pages = {1654--1666},
  doi = {10.1177/13872877261424925}
}
Kostenlos starten →